Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 June 2022 | Story Lacea Loader
UFS drops wearing of masks on campus

The management of the University of the Free State (UFS) has taken note of the announcement by the Minister of Health, Dr Joe Phaahla, in the Government Gazette on 22 June 2022, in which COVID-19 regulations were repealed.

Minister Phaahla stated that, as from 22 June, South Africans no longer have to wear masks, and that limits on gatherings and border checks for COVID-19, as well as the need to be vaccinated in order to enter South Africa, have also been dropped.

The UFS COVID-19 Regulations and Required Vaccination Policy has created an environment that the university management regards as safe. This, together with yesterday’s announcement by the Minister, was considered, and a decision was made that the wearing of masks on campus or in any building on campus is no longer compulsory.

However, the UFS COVID-19 Regulations and Required Vaccination Policy remains in place. Campus access control is still in place, and staff, students, and visitors are expected to upload a COVID-19 vaccination certificate or a negative PCR or antigen test result to obtain access to the campuses.

The wearing of masks is still recommended and will be of value especially in the following instances:

1.     For immune-compromised staff, students, and visitors
2.     For persons who are ill with, e.g., flu, colds, coughs, etc.

In the case of staff and students working in public and private hospitals, or any other external laboratory/facility, the wearing of masks is determined by the hospital or the external laboratory/facility and not by the UFS. In any other environment where students or staff are under the regulations of external organisations, these regulations will take precedence. 

Staff and students are encouraged to feel free to continue wearing masks, including those with comorbidities, as masks have been shown to be helpful in preventing the spread of respiratory diseases. Good health-care behaviour remains important as COVID-19 is still a reality.

The university management will decide in due course on the possible upliftment of restrictions on public gatherings.

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za

News Archive

UFS cardiac team does pioneering work
2017-10-29

Description: ' 000 Cardiac Pioneers Tags: Cardiac Pioneers 

“With the use of endomyocardial biopsies, the team hopes to treat viruses unique
to Southern Africa, as well as other underlying causes of dilated cardiomyopathy.”

Photo: iStock

Members of the University of the Free State’s (UFS) Cardiac team had various achievements at national and international level this year. The Robert WM Frater Cardiovascular Research Centre in the Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.

With an Afrocentric research focus, Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition, and 50% of patients who have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made, where virus infections of the heart muscle, or myocarditis, have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

According to Prof Mokoali Makotoko, Head of the Department of Cardiology, more than 1 500 new cases of heart failure are identified at the Universitas Academic Hospital annually, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies, the team hopes to treat viruses unique to Southern Africa, as well as other underlying causes of dilated cardiomyopathy.”

The study is a project that flows from Prof Makotoko’s PhD. The project is being run with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

 "More than 1 500 new cases of heart failure are identified at the Universitas Academic Hospital annually, of which approximately 30% are attributed to cardiomyopathy."

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept